Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
AGLE Aeglea BioTherapeutics
0.520+0.016+3.17%
Close
02/06 16:00 ET
0.500-0.020-3.85%
Pre Mkt Price 02/07 05:28 ET
High
0.528
Open
0.495
Turnover
113.10K
Low
0.495
Pre Close
0.504
Volume
219.09K
Pre-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Aeglea BioTherapeutics (NASDAQ:AGLE) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a research report sent to investors on Monday morning. The brokerage issued a hold rating on the biote
Aeglea BioTherapeutics (NASDAQ:AGLE) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a report published on Monday. The firm issued a hold rating on the biotechnology company's stock. AGLE
Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Receives Consensus Rating of "Moderate Buy" From Analysts
Shares of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE – Get Rating) have been assigned a consensus recommendation of "Hold" from the six research firms that are covering the stock, MarketBeat.com repo
Aeglea BioTherapeutics (NASDAQ:AGLE) Share Price Passes Below 50-Day Moving Average of $0.57
Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE – Get Rating)'s share price passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.57 and traded as
Aeglea Bio Therapeutics On Jan 13 Got Notice From Nasdaq That Co No Longer Complies With Minimum Bid Price Requirement For Continued Listing On Nasdaq
Aeglea Bio Therapeutics On Jan 13 Got Notice From Nasdaq That Co No Longer Complies With Minimum Bid Price Requirement For Continued Listing On Nasdaq
Aeglea BioTherapeutics Cuts 15% of Workforce, Halts Development Programs; COO to Leave; Shares Fall
11:38 AM EST, 01/06/2023 (MT Newswires) -- Aeglea BioTherapeutics (AGLE) said Friday it has reduced about 15% of its workforce and is halting preclinical work on Cystinuria and other unnamed pipeline
Aeglea BioTherapeutics: Operating Chief Leslie Sloan to Depart >AGLE
Aeglea BioTherapeutics ATo Reduce Workforce By 15%
Aeglea BioTherapeutics aTo Reduce Workforce By 15%
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersVyant Bio (NASDAQ:VYNT) stock moved upwards by 111.7% to $1.63 during Thursday's pre-market session. The company's market cap stands at $9.6 million. NovoCure (NASDAQ:NVCR) stock rose 68.72% to
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
Gainers Gorilla Technology Group Inc. (NASDAQ:GRRR) shares rose 162% to $21.30 in pre-market trading after jumping over 35% on Friday. Gorilla Technology recently said it is entering the MENA region
Company Overview
More
Aeglea Biotherapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe in December 2013 and is headquartered in Austin, TX.
CEO： Mr. Jeffrey M. Goldberg
Market： NASDAQ
Listing Date： 04/07/2016
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet